Immediate Impact
1 from Science/Nature 56 standout
Citing Papers
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
2025 Standout
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
2025 Standout
Works of Michael Desch being referenced
Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon‐like peptide‐1 receptor agonist BI 456906
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael Desch | 252 | 116 | 113 | 114 | 20 | 483 | |
| Joann L. Data | 149 | 140 | 52 | 97 | 12 | 527 | |
| A. Elizabeth Linder | 112 | 59 | 96 | 62 | 28 | 444 | |
| Paul F. Boston | 277 | 32 | 37 | 85 | 16 | 562 | |
| Gordana Župan | 154 | 189 | 29 | 146 | 34 | 543 | |
| Carlos M. Villalón | 162 | 164 | 71 | 141 | 12 | 528 | |
| Peter Bond | 162 | 69 | 102 | 39 | 16 | 435 | |
| Ritushree Kukreti | 169 | 74 | 42 | 133 | 34 | 473 | |
| Giia-Sheun Peng | 222 | 150 | 45 | 30 | 20 | 538 | |
| Bo Wei | 103 | 36 | 55 | 28 | 40 | 516 | |
| Bu‐Chin Yu | 206 | 54 | 87 | 39 | 14 | 488 |
All Works
Login with ORCID to disown or claim papers
Loading papers...